Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
B Cell Immunology for the Clinical Dermatologist
Description
In this presentation, Chris Richardson discusses the clinical relevance of B cell immunology for dermatologists, emphasizing its importance in various skin diseases and treatment modalities. The lecture covers B cell development, from progenitors in the bone marrow to their roles in immunity and pathology. Specific topics include B cell markers, the significance of Bruton's tyrosine kinase (BTK) in B cell maturation, and how B cells contribute to autoimmune diseases like pemphigus and conditions treated with therapies such as rituximab and BTK inhibitors like ibrutinib. The importance of immunoglobulins (IgG, IgM, and IgA) is outlined, highlighting their roles in diagnosing infections and immune responses. The presentation also discusses the role of B cells in chronic urticaria and how different regulatory mechanisms can lead to immune dysregulation. Additionally, antibodies, their classifications, and therapeutic approaches for B cell-related conditions are explored, illustrating the complex interactions between B cells and T cells in adaptive immunity. Overall, the lecture integrates foundational immunological concepts with their practical applications in dermatology, encouraging clinicians to consider B cell functions when diagnosing and treating skin diseases.
View moreConclusions
- B cells play a significant role in various dermatological diseases such as immunodeficiencies, cutaneous lymphomas, and autoimmune disorders.
- Clinical relevance of B cell biology includes the use of targeted therapies like monoclonal antibodies, which are integral in treatments for diseases relying on B cell function.
- B cell development starts in the bone marrow and undergoes several stages, ultimately leading to the production of antibodies.
- The importance of BTK (Bruton's tyrosine kinase) in B cell development and signaling underscores its relevance in immunodeficiencies and therapies.
- The differentiation of B cells into memory and plasma cells is crucial for an effective immune response against pathogens.
- Therapies targeting B cell survival and function, such as BAFF antagonists and anti-CD20 therapies, show promise in managing autoimmune skin conditions.
- Understanding B cell signaling pathways and their interactions with T cells and other immune cells is critical for developing new treatments.
- The presence of specific B cell markers such as CD19 and CD20 provides targets for monoclonal antibody therapies.
- Immunological testing, including serum protein electrophoresis (SPEP), aids in diagnosing conditions associated with B cell abnormalities, like hypergammaglobulinemia.
- Janeway. Immunobiology. 2001.
- Dalakas Nat Clin Pract Neurol 10.1038/ncpneuro0901
- Nature Reviews Immunology volume 14, pages719-730 (2014)
- Nature Clinical Practice Rheumatology volume 2, pages654-660 (2006)
- Maloney DG. N Engl J Med 2012;366:2008-2016.
- J Clin Invest. 2003;112(11):1636-1638.
- Blood 2014 123:1772-1774.
- Virology 277 (1): 2-5.
- Ann Rheum Dis. 2013 Dec;72(12):1947-55.